Patient-Derived Xenografts as an Innovative Surrogate Tumor Model for the Investigation of Health Disparities in Triple Negative Breast Cancer

• Príomhchruthaitheoirí: Margarite D. Matossian (Údar), Alexandra A. Giardina (Údar), Maryl K. Wright (Údar), Steven Elliott (Údar), Michelle M. Loch (Údar), Khoa Nguyen (Údar), Arnold H. Zea (Údar), Frank H. Lau (Údar), Krzysztof Moroz (Údar), Adam I. Riker (Údar), Steven D. Jones (Údar), Elizabeth C. Martin (Údar), Bruce A. Bunnell (Údar), Lucio Miele (Údar), Bridgette M. Collins-Burow (Údar), Matthew E. Burow (Údar)
• Formáid: LEABHAR
• Foilsithe / Cruthaithe: Mary Ann Liebert, 2020-09-01T00:00:00Z.
• Ábhair: article
• Rochtain ar líne: Connect to this object online.

Despite a decline in overall incidence rates for cancer in the past decade, due in part to impressive advancements in both diagnosis and treatment, breast cancer (BC) remains the leading cause of cancer-related deaths in women. BC alone accounts for ?30% of all new cancer diagnoses in women worldwid...